Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL655224 | 0.94 | — | — | |
| SCHEMBL3172597 | 0.94 | CA4 (0.50) | CA4CASP1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL508199 | 0.94 | — | — | |
| Potassium Ion SCHEMBL5325780 | 0.94 | — | — | |
| Silver SCHEMBL1533990 | 0.94 | — | — | |
| SCHEMBL28665122 | 0.75 | CA4 (0.50) | CA4CASP1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL2392558 | 0.73 | CA4 (0.36) | CA4 | |
| Citric Acid SCHEMBL235474 | 0.73 | CA4 (0.89) | CA4CASP1ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL1000366 | 0.72 | CA4 (0.38) | CA4CASP1ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL2892041 | 0.71 | FAAH (0.40) | CA4CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567478-B1 | METHOD OF PRODUCING NITRILE COMPOUNDS FROM ETHYLENICALLY-UNSATURATED COMPOUNDS | RHODIA OPERATIONS (FR) | 2009-10-21 | — | — | EP | claimed |
| US-7485741-B2 | Method of producing nitrile compounds from ethylenically-unsaturated compounds | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2009-02-03 | — | — | US | claimed |
| US-20060142609-A1 | Method of producing nitrile compounds from ethylenically-unsaturated compounds | INVISTA NORTH AMERICA SARL | 2006-06-29 | — | — | US | claimed |
| US-7485741-B2 | Method of producing nitrile compounds from ethylenically-unsaturated compounds | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2009-02-03 | — | — | US | disclosed |
| US-20060142609-A1 | Method of producing nitrile compounds from ethylenically-unsaturated compounds | INVISTA NORTH AMERICA SARL | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142609-A1 | Method of producing nitrile compounds from ethylenically-unsaturated compounds | FASN, FABP4, ALOX12 | CA4 1598/4885CASP1 596/4885ALDH1A1 1458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.